The antisaccade task as an index of sustained goal activation in working memory: Modulation by nicotine

Psychopharmacology

Volumn 188, Issue 4, 2006, Pages 521-529

  Rycroft, Nicola ^a   Hutton, Samuel B ^a   Rusted, Jennifer M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Antisaccade; Inhibition; Intention; Nicotine; Working memory

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EYE FIXATION; FEMALE; HUMAN; MALE; MODULATION; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SMOKING; TASK PERFORMANCE; WORKING MEMORY; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECT; MEMORY; PHYSIOLOGY;

ADULT; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MEMORY; NICOTINE; NICOTINIC AGONISTS; SACCADES; SMOKING;

EID: 34248576554     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0455-7     Document Type: Article

References (62)

1. Arnold HM, Nelson CL, Sarter M, Bruno JP (2003) Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats. Psychopharmacology 165:346-358
2. Bates T, Pellett O, Stough C, Mangan G (1994) Effects of smoking on simple and choice reaction time. Psychopharmacology 114:365-368
3. Bettany JH, Levin ED (2001) Ventral hippocampal alpha-7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial arm-maze. Pharmacol Biochem Behav 70:464-467
4. Buccafusco JJ, Jackson WJ, Terry AV Jr, Marsh KC, Decker MW, Arneric SP (1995) Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256-266
5. Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM (2005) Long lasting cognitive improvement with nicotine receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol Sci 26:352-360
6. Calkins ME, Curtis CE, Iacono WG, Grove WM (2004) Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients. Schizophr Res 71:167-178
7. Clarke PBS, Reuben M (1996) Release of [3H]-noradrenalin from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol 117:595-606
8. Corrigall WA, Coen KM, Adamson L (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284
9. Dar R, Frenk H (2004) Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology 173:18-26
10. de Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76:135-157
11. Della Casa V, Hofer I, Feldon J (1999) Latent inhibition in smokers vs nonsmokers: interaction with number or intensity of preexposures. Pharmacol Biochem Behav 62:353-359
12. Depatie L, O'Driscoll GA, Holahan AV, Atkinson V, Thavundayil JX, Kin NNY, Lal S (2002) Nicotine and behavioural markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27:1056-1070
13. Edginton T, Rusted JM (2003) Separate and combined effects of scopolamine and nicotine on retrieval-induced forgetting. Psychopharmacology 170:351-357
14. Eenshuistra RM, Ridderinkhof KR, van der Molen MW (2004) Age-related changes in antisaccade performance: inhibitory control or working-memory engagement? Brain Cogn 56:177-188
15. Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE, London ED (2001) Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A 98:4728-4733
16. Ettinger U, Kumari V, Zachariah E, Galea A, Crawford TJ, Corr PJ, Taylor D, Das M, Sharma T (2003a) Effects of procyclidine on eye movements in schizophrenia. Neuropsychopharmacology 28:2199-2208
17. Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ (2003b) Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology 40:620-628
18. Fagerström KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235-241
19. Fischer B, Weber H (1997) Effects of stimulus conditions on the performance of antisaccades in man. Exp Brain Res 116:191-200
20. Findlay JM, Walker R (1999) A model of saccade generation based on parallel processing and competitive inhibition. Behav Br Sci 22:661-721
21. Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell, MAH (1996) Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 127:31-38
22. Griesar WS, Zajdel DP, Oken BS (2002) Nicotine effects on alertness and spatial attention in non-smokers. Nicotine Tob Res 4:185-194
23. Godijn R, Theeuwes J (2002) Programming of endogenous and exogenous saccades: evidence for a competitive integration model. J Exp Psychol Hum Percept Perform 28:1039-1054
24. Hallett PE (1978) Primary and secondary saccades to goals defined by instructions. Vis Res 18:1279-1296
25. Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R. (2004) Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29:1378-1385
26. Hutton SB, Crawford TJ, Puri BK, Duncan LJ, Chapman M, Kennard C, Barnes TRE, Joyce EM (1998) Smooth pursuit and saccadic abnormalities in first-episode schizophrenia. Psychol Med 28:685-692
27. Hutton SB, Joyce EM, Barnes TRE, Kennard C (2002) Saccadic distractibility in first-episode schizophrenia. Neuropsychologia 40:1729-1736
28. Hutton SB, Huddy V, Barnes TR, Robbins TW, Crawford TJ, Kennard C, Joyce EM (2004) The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia. Biol Psychiatry 56:553-559
29. Khan SA, Ford K, Timney B, Everling F (2003) Effects of ethanol on anti-saccade task performance. Exp Brain Res 150:68-74
30. Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self medication hypothesis. Exp Brain Res 29:1021-1034
31. Kumari V, Gray JA, Ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SCR, Simmons A, Sharma T (2003) Cognitive effects of nicotine in humans: an fMRI study. NeuroImage 19:1002-1013
32. Larrison AL, Briand KA, Sereno AB (2004) Nicotine improves antisaccade performance without affecting prosaccades. Hum Psychopharmacol 19:409-419
33. Larrison-Faucher AL, Matorin AA, Sereno AB (2004) Nicotine reduces antisaccade errors in task impaired subjects. Prog Neuro-psychopharmacol Biol Psychiatry 28:505-516
34. Leigh RJ, Kennard C (2004) Using saccades as a research tool in the clinical neurosciences. Brain 127:460-477
35. Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, Olincy A, Freedman R (1998) Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci 12:195-201
36. Levin ED, Christopher NC (2002) Persistence of nicotinic agonist RJR 2403 induced working memory improvements in rats. Drug Dev Res 55:97-103
37. Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioural characterisation, pharmacological specification and anatomical localisation. Psychopharmacology 184:523-539
38. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology 140:135-141
39. Mancuso G, Lejeune M, Ansseau M (2001) Cigarette smoking and attention: processing speed or specific effects? Psychopharmacology 155:372-378
40. Martin-Ruiz CM, Haroutunian VH, Long P, Young AH, Davis KL, Perry EK, Court JA (2003) Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol Psychiatry 54:1222-1233
41. Massen C (2004) Parallel programming of exogenous and endogenous components in the antisaccade task. Q J Exp Psychol A 57:475-498
42. Mitchell JP, Macrae CN, Gilchrist ID (2002) Working memory and the suppression of reflexive saccades. J Cogn Neurosci 14:95-103
43. Munoz DP, Everling S (2004) Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci 5:218-228
44. Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, Thaker GK (2004) Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology 174(3):334-340
45. Nieuwenhuis S, Broerse A, Nielen MMA, de Jong R (2004) A goal activation approach to the study of executive function: An application to antisaccade tasks. Brain Cogn 56:198-214
46. Nordberg A (2001) Nicotinic receptor abnormalities in Alzheimer's disease: therapeutic implications. Biol Psychiatry 49:200-210
47. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Biol Psychiatry 61:75-111
48. Perkins KA, Donny E, Caggiula AR (1999) Sex differences in nicotine effects and self-administration: review of human and animal evidence. Nicotine Tob Res 1(4):301-315
49. Pierrot-Deseilligny C, Müri RM, Ploner CJ, Gaymard B, Demeret S, Rivaud-Pechoux S (2003) Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour. Brain 126:1460-1473
50. Poltavski DV, Petros T (2005) Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers. Physiol Behav 83(5):833-843
51. Powell J, Dawkins L, Davis RE (2002) Smoking, reward responsiveness and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51:151-163
52. Reuben M, Clarke PBS (2000) Nicotine evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology 39:290-299
53. Reuter B, Kathmann N (2004) Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia. Acta Psychologica 115:255-269
54. Roberts RJ, Hager LD, Heron C (1994) Prefrontal cognitive processes: working memory and inhibition in the antisaccade task. Biol Psychiatry 123:374-393
55. Roos YBWEM, de Jongh FE, Crevits L (1995) The effects of smoking on anti-saccades. Neuro-ophthalmology 15:3-8
56. Rycroft N, Rusted JM, Hutton SB (2005) Acute effects of nicotine on visual search tasks in young adult smokers. Psychopharmacology 181:160-169
57. Stuyven E, Van der Goten K, Vandierendonck A, Claeys K, Crevits L (2000) The effect of cognitive load on saccadic eye movements. Acta Psychologica 104:69-85
58. Unsworth N, Schrock JC, Engle RW (2004) Working memory capacity and the antisaccade task: individual differences in voluntary saccade control. J Exp Psychol Learn Mem Cogn 30:1302-1321
59. Vidal C, Changeux JP (1993) Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56:23-32
60. Warburton DM, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmacology 115:539-542
61. West RJ, Jarvis MJ (1986) Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav 25:727-731
62. Witte EA, Davidson MC, Marrocco RT (1997) Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology 132:324-334